Skip to main content
. 2025 Jun 26;26(13):6139. doi: 10.3390/ijms26136139
ADC antibody drug conjugate
AKTi AKT inhibitor
ANOVA analysis of variance
ATCC American Type Culture Collection
DMEM Dulbecco’s modified Eagle’s medium
DMSO dimethyl sulfoxide
DNMT1 DNA (cytosine-5)-methyltransferase 1
DPBS Dulbecco’s phosphate buffered saline
EGFR epidermal growth factor receptor
ER estrogen receptor
ERK extracellular signal-regulated kinase
FBS fetal bovine serum
FDA Food and Drug Administration
FLT3 FMS-like tyrosine kinase 3
GvHD graft-versus-host disease
HER2 human epidermal growth factor 2
IL6 interleukin 6
JAK Janus kinase
JAK2i JAK2 inhibitor
MEK MAP kinase/ERK kinase
MEKi MEK inhibitor
mTOR mammalian target of rapamycin
MTT 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide
PARP1 poly [adenosine diphosphate (ADP)-ribose] polymerase 1
PD-L1 programmed cell death ligand 1
PDLIM4 PDZ and LIM domain protein 4
PKI protein kinase inhibitor
PR progesterone receptor
PVDF polyvinylidene difluoride
RET rearranged during transfection
RTK receptor tyrosine kinase
STAT3 signal transducer and activator of transcription 3
SYK spleen tyrosine kinase
TNBC triple-negative breast cancer
TYK2 tyrosine kinase 2
VHL von Hippel-Lindau disease tumor suppressor
XIAP X-linked inhibitor of apoptosis protein